◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

JCR Pharmaceuticals Co., Ltd. (4552) Financial History

Name: JCR Pharmaceuticals Co., Ltd. (4552) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

JCR Pharmaceuticals Co., Ltd. (4552) operates in the Drug Manufacturers - General industry and is headquartered in Ashiya, Japan with about 985 employees. Its market capitalization is roughly JPY 62 billion. In the fiscal year ended 2026-03-31, 4552 reported JPY 40.3B in revenue and JPY 2.2B in net income.

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, biopharmaceuticals, medical equipment, regenerative medicines, and drug substances in Japan.

Interactive charts & full statements →

4552 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 40.3B	JPY 33.1B	JPY 42.9B	JPY 34.3B	—
Gross Profit	JPY 30.2B	JPY 22.2B	JPY 31.3B	JPY 25.5B	—
Operating Income (EBIT)	JPY 556M	(JPY 6.2B)	JPY 7.5B	JPY 5.0B	—
Net Income	JPY 2.2B	(JPY 4.5B)	JPY 5.5B	JPY 3.8B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4552 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	—	(JPY 2.5B)	(JPY 2.5B)	(JPY 2.7B)	(JPY 2.2B)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4552 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 109.2B	JPY 104.8B	JPY 102.2B	JPY 94.9B	—
Total Liabilities	JPY 61.9B	JPY 57.1B	JPY 45.8B	JPY 42.5B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4552 viewer.

Other Companies in Drug Manufacturers - General

4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion
BAYN · Bayer Aktiengesellschaft — $47 billion
2630 · Vigonvita Life Sciences Co., Ltd. — $20 billion
9637 · Alebund Pharmaceuticals (Jiangsu) Limited — $11 billion
1666 · Tong Ren Tang Technologies Co. Ltd. — $4 billion

← 4549 All “0-9” companies 4553 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.